| (Values in U.S. Thousands) | Mar, 2025 | Sep, 2024 | Jun, 2024 | Mar, 2024 | Sep, 2023 |
| Sales | 1,759 | 1,882 | 1,703 | 1,026 | 51 |
| Sales Growth | -6.54% | +10.51% | +65.98% | +1,911.76% | -42.70% |
| Net Income | -317 | -898 | -1,246 | -1,687 | -2,358 |
| Net Income Growth | +64.70% | +27.93% | +26.14% | +28.46% | +2.72% |
Willow Biosciencesinc (WLLW.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.